| 1 |
卫生部医管司. 卫生部办公厅关于启动心脏死亡捐献器官移植试点工作的通知.卫办医管发[2011]62号[DB/OL]. (2019-01-17)[2011-05-03].
URL
|
| 2 |
国家卫生和计划生育委员会脑损伤质控评价中心. 脑死亡判定标准与技术规范(成人质控版)[J/CD]. 中华移植杂志：电子版，2015, 9(1)：13-16.
|
| 3 |
中华医学会器官移植学分会. 中国心脏死亡器官捐献工作指南(第2版)[J/CD]. 中华移植杂志：电子版，2012, 6(3)：43-46.
|
| 4 |
Snell GI, Paraskeva M, Westall GP. Donor selection and management[J]. Semin Respir Crit Care Med, 2013, 34(3): 361-370.
|
| 5 |
Baldwin MR, Peterson ER, Easthausen I, et al. Donor age and early graft failure after lung transplantation: a cohort study[J]. Am J Transplant, 2013, 13(10): 2685-2695.
|
| 6 |
Bonser RS, Taylor R, Collett D, et al. Effect of donor smoking on survival after lung transplantation: a cohort study of a prospective registry[J]. Lancet, 2012, 380(9843): 747-755.
|
| 7 |
Chaney J, Suzuki Y, Cantu E 3rd, et al. Lung donor selection criteria[J]. J Thorac Dis, 2014, 6(8): 1032-1038.
|
| 8 |
王振兴，陈静瑜，郑明峰，等. 肺移植供肺获取100例：冷缺血时间≥6 h及肺减容对预后的影响[J]. 中国组织工程研究，2012, 16 (5)：835-838.
|
| 9 |
Gammie JS, Stukus DR, Pham SM, et al. Effect of ischemic time on survival in clinical lung transplantation[J]. Ann Thorac Surg, 1999, 68(6): 2015-2020.
|
| 10 |
Orens JB, Boehler A, de Perrot M, et al. A review of lung transplant donor acceptability criteria[J]. J Heart Lung Transplant, 2003, 22(11): 1183-1200.
|
| 11 |
Studer SM, Orens JB. Cadaveric donor selection and management[J]. Semin Respir Crit Care Med, 2006, 27(5): 492-500.
|
| 12 |
Van Raemdonck D, Neyrinck A, Verleden GM, et al. Lung donor selection and management[J]. Proc Am Thorac Soc, 2009, 6(1): 28-38.
|
| 13 |
Mulvihill MS, Gulack BC, Ganapathi AM, et al. The association of donor age and survival is independent of ischemic time folloing deceaseddonor lung transplantation[J]. Clin Transplant, 2017, 31(7).
|
| 14 |
Chambers DC, Yusen RD, Cherikh WS, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung and Heart-Lung Transplantation Report-2017; focus theme: allograft ischemic time[J]. J Heart Lung Transplant, 2017, 36(10): 1047-1059.
|
| 15 |
Hayes D Jr, Hartwig MG, Tobias JD, et al. Lung transplant center volume ameliorates adverse influence of prolonged ischemic time on mortality[J]. Am J Transplant, 2017, 17(1): 218-226.
|
| 16 |
Snell GI, Westall GP. Selection and management of the lung donor[J]. Clin Chest Med, 2011, 32(2): 223-232.
|
| 17 |
马春林，梁道业，郑福奎．高呼气末正压在神经源性肺水肿机械通气中的作用[J]. 中华危重病急救医学杂志，2014, 26(5)：339-342.
|
| 18 |
冯艳，于国东，王华，等. 神经源性肺水肿的液体治疗策略探讨[J]. 中华神经医学杂志，2015, 14(2)：176-180.
|
| 19 |
Minambres E, Rodrigo E, Ballesteros M, et al. Impact of restrictive fluid balance focused to increase lung procurement on renal function after kidney transplantation[J]. Nephrol Dial Transplant, 2010, 25(7): 2352-2356.
|
| 20 |
Munshi L, Keshavjee S, Cypel M. Donor management and lung preservation for lung transplantation[J]. Lancet Respir Med, 2013, 1(4): 318-328.
|
| 21 |
Pennefather S, Bullock R, Mantle D, et al. Use of low dose arginine vasopressin to support brain-dead donors[J]. Transplantation, 1995, 59(1): 58-62.
|
| 22 |
Tuttle-Newhall J, Collins B, Kuo P, et al. Organ donation and treatment of multi-organ donor[J]. CurrProb Surg, 2003, 40(5): 266-310.
|
| 23 |
Determann R, Royakkers A, Wolthuis E, et al. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial[J]. Crit Care, 2010, 14(1): R1.
|
| 24 |
Mascia L, Pasero D, Slutsky A, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation[J]. JAMA, 2010, 304(23): 2620-2627.
|
| 25 |
Howlett T, Keogh A, Perry L, et al. Anterior and posterior pituitary function in brain-stem-dead donors: a possible role for hormonal replacement therapy[J]. Transplantation, 1989, 47(5): 828-834.
|
| 26 |
Shemie S, Ross H, Pagliarello J, et al. Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential[J]. CMAJ, 2006, 174(6): S13-S30.
|
| 27 |
Dimopoulou I, Tsagarakis S, Anthi A, et al. High prevalence of decreased cortisol reserve in brain-dead potential organ donors[J]. Crit Care Med, 2003, 31(4): 1113-1117.
|
| 28 |
Follette D, Rudich S, Babcock W. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death[J]. J Heart Lung Transplant, 1998, 17(4): 423-429.
|
| 29 |
Macdonald P, Aneman A, Bhonagiri D, et al. A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors[J]. Crit Care Med, 2012, 40(5): 1635-1645.
|
| 30 |
Arnaoutakis G, Allen J, Merlo C, et al. Low potassium dextran is superior to University of Wisconsin solution in high-risk lung transplant recipients[J]. J Heart Lung Transplant, 2010, 29(12): 1380-1387.
|
| 31 |
Thabut G, Vinatier I, Brugière O, et al. Influence of preservation solution on early graft failure in clinical lung transplantation[J]. Am J Respir Crit Care Med, 2001, 164(7): 1204-1208.
|
| 33 |
Sasaki M, Muraoka R, Chiba Y, et al. Influence of pulmonary arterial pressure during flushing on lung preservation[J]. Transplantation, 1996, 61(1): 22-27.
|